
### [MONDO:0000590](http://purl.obolibrary.org/obo/MONDO_0000590)
**Label:** autoimmune disease of peripheral nervous system

**Subclasses:** [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0018845](http://purl.obolibrary.org/obo/MONDO_0018845) (focal myositis), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0018325](http://purl.obolibrary.org/obo/MONDO_0018325) (juvenile myasthenia gravis), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0018326](http://purl.obolibrary.org/obo/MONDO_0018326) (transient neonatal myasthenia gravis), [MONDO:0009175](http://purl.obolibrary.org/obo/MONDO_0009175) (eosinophilic fasciitis (disease)), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0018324](http://purl.obolibrary.org/obo/MONDO_0018324) (adult-onset myasthenia gravis), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0020122](http://purl.obolibrary.org/obo/MONDO_0020122) (idiopathic inflammatory myopathy), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0016609](http://purl.obolibrary.org/obo/MONDO_0016609) (inflammatory myopathy with abundant macrophages), [MONDO:0018826](http://purl.obolibrary.org/obo/MONDO_0018826) (Lewis-Sumner syndrome), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0016610](http://purl.obolibrary.org/obo/MONDO_0016610) (idiopathic eosinophilic myositis), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0016099](http://purl.obolibrary.org/obo/MONDO_0016099) (overlap myositis), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0019344](http://purl.obolibrary.org/obo/MONDO_0019344) (Antisynthetase syndrome), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0018011](http://purl.obolibrary.org/obo/MONDO_0018011) (juvenile overlap myositis), [MONDO:0008036](http://purl.obolibrary.org/obo/MONDO_0008036) (myasthenia, limb-girdle, autoimmune), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0016098](http://purl.obolibrary.org/obo/MONDO_0016098) (immune-mediated necrotizing myopathy), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0018010](http://purl.obolibrary.org/obo/MONDO_0018010) (juvenile idiopathic inflammatory myopathy), [MONDO:0006866](http://purl.obolibrary.org/obo/MONDO_0006866) (neonatal myasthenia gravis), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0007691](http://purl.obolibrary.org/obo/MONDO_0007691) (Guillain-Barre syndrome), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0011768](http://purl.obolibrary.org/obo/MONDO_0011768) (myasthenia gravis with thymus hyperplasia), [MONDO:0019606](http://purl.obolibrary.org/obo/MONDO_0019606) (simple cryoglobulinemia), 

**Mapped go classes:** [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0032288](http://purl.obolibrary.org/obo/GO_0032288) (myelin assembly), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0043218](http://purl.obolibrary.org/obo/GO_0043218) (compact myelin), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0032060](http://purl.obolibrary.org/obo/GO_0032060) (bleb assembly), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.56%
- [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome) 53.23%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.61%
- [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome) 51.61%
- [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome) 51.61%
- [GO:0005767](http://purl.obolibrary.org/obo/GO_0005767) (secondary lysosome) 51.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.97%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005974](http://purl.obolibrary.org/obo/GO_0005974) (obsolete fibrinogen gamma chain)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005973](http://purl.obolibrary.org/obo/GO_0005973) (obsolete fibrinogen beta chain)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005972](http://purl.obolibrary.org/obo/GO_0005972) (obsolete fibrinogen alpha chain)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005970](http://purl.obolibrary.org/obo/GO_0005970) (null)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005961](http://purl.obolibrary.org/obo/GO_0005961) (null)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005959](http://purl.obolibrary.org/obo/GO_0005959) (null)) 36.97%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005957](http://purl.obolibrary.org/obo/GO_0005957) (obsolete debranching enzyme)) 36.97%


